Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Boda

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Orvosi Hetilap|September 11, 1977
[Study of the heparin-neutralizing effect of plasma in disorders of hemostasis (clinical use of the "heparin-thrombin coagulation time")]M Misz, Z Boda, K Rák
Orvosi Hetilap|June 25, 1978
[Heparin-induced thrombocytopenia]M Udvardy, Z Boda, K Rák
Antibiotiki|August 1, 1980
[Ability of vancomycin-group antibiotics to induce or to inhibit thrombocyte agglutination]K Rák, Z Boda, F Sztaricskai
Orvosi Hetilap|August 26, 1999
[Clinical aspects of heparin induced thrombocytopenia]M Udvardy, Z Boda, K Rák
Thrombosis and Haemostasis|March 1, 1993
Platelet factor XIII becomes active without the release of activation peptide during platelet activationL Muszbek, J Polgár, Z Boda
Orvosi Hetilap|August 11, 1985
[IIB-type Willebrand disease (a case of increased ristomycin-induced aggregation)]Z Boda, J Hársfalvi, K Rák
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1996
Studies of the platelet filter test (shear dependent platelet aggregation) in patients with uncommon haemorrhagic disordersZ Boda, I Tornai, K Rak
Orvosi Hetilap|August 5, 1990
[Thrombotic changes in hemostasis following streptokinase therapy in myocardial infarct]M Udvardy, J Hársfalvi, Z Boda, et al.
Thrombosis and Haemostasis|February 19, 1990
Thrombotic changes in haemostasis following intravenous streptokinase treatment for acute myocardial infarctionM Udvardy, J Hársfalvi, Z Boda, et al.
Orvosi Hetilap|November 10, 1991
[Successful treatment of severe hemorrhage by using thrombocyte suspension with cryoprecipitate in type III Willebrand disease]Z Boda, G Pfliegler, J Hársfalvi, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Orvosi Hetilap|September 11, 1977
[Study of the heparin-neutralizing effect of plasma in disorders of hemostasis (clinical use of the "heparin-thrombin coagulation time")]M Misz, Z Boda, K Rák
Orvosi Hetilap|June 25, 1978
[Heparin-induced thrombocytopenia]M Udvardy, Z Boda, K Rák
Antibiotiki|August 1, 1980
[Ability of vancomycin-group antibiotics to induce or to inhibit thrombocyte agglutination]K Rák, Z Boda, F Sztaricskai
Orvosi Hetilap|August 26, 1999
[Clinical aspects of heparin induced thrombocytopenia]M Udvardy, Z Boda, K Rák
Thrombosis and Haemostasis|March 1, 1993
Platelet factor XIII becomes active without the release of activation peptide during platelet activationL Muszbek, J Polgár, Z Boda
Orvosi Hetilap|August 11, 1985
[IIB-type Willebrand disease (a case of increased ristomycin-induced aggregation)]Z Boda, J Hársfalvi, K Rák
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1996
Studies of the platelet filter test (shear dependent platelet aggregation) in patients with uncommon haemorrhagic disordersZ Boda, I Tornai, K Rak
Orvosi Hetilap|August 5, 1990
[Thrombotic changes in hemostasis following streptokinase therapy in myocardial infarct]M Udvardy, J Hársfalvi, Z Boda, et al.
Thrombosis and Haemostasis|February 19, 1990
Thrombotic changes in haemostasis following intravenous streptokinase treatment for acute myocardial infarctionM Udvardy, J Hársfalvi, Z Boda, et al.
Orvosi Hetilap|November 10, 1991
[Successful treatment of severe hemorrhage by using thrombocyte suspension with cryoprecipitate in type III Willebrand disease]Z Boda, G Pfliegler, J Hársfalvi, et al.
Pageof 8